For acute and chronic pulmonary diseases with abnormal secretion and impaired expectoration, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis and bronchial asthma; for preventive treatment of postoperative pulmonary complications; and for respiratory distress syndrome in premature and newborn infants. The first product of its kind in China to pass generic consistency evaluation, and selected in the fourth national centralised drug procurement.
